SoftWave + PRP: The Regenerative Combo Protocol for Stubborn Injuries

There's a particular kind of patient I see a lot, and you might be one of them. The injury isn't new. It's been eighteen months, maybe three years. You've done physical therapy, twice. You've had a cortisone shot that bought you a season. You've rested it, and resting it didn't fix it, it just made you weaker and then it hurt again the moment you did anything. Somewhere along the way you stopped calling it an injury and started calling it "my elbow" or "my knee," like it's a permanent roommate.

I'm Dr. Farhan Abdullah, medical director at Magnolia Functional Wellness in Southlake and a board-certified internal medicine physician who still works in a Dallas hospital. When somebody with that history sits down across from me, the interesting question usually isn't which single treatment we should try next. They've already tried single treatments, one at a time, for years. The better question is whether stacking two different regenerative approaches gets us somewhere that neither one reaches on its own.

That's what this post is about: pairing SoftWave shockwave therapy with platelet-rich plasma. It isn't a gimmick, and it isn't right for everybody. But for genuinely stubborn tissue, the logic behind combining them is sound, and the evidence has gotten more interesting than it used to be.

Two Treatments, Two Completely Different Jobs

The reason this pairing makes sense starts with what each one actually does, because they're not redundant.

SoftWave delivers unfocused acoustic pressure waves into tissue. No needle, no incision. The mechanical energy does three things that matter here. It triggers angiogenesis, meaning it prompts new small blood vessels to form in tissue that's often chronically underperfused. Tendons and fascia have notoriously poor blood supply, and that's a big part of why they heal so badly. It recruits resident stem cells toward the treatment zone. And it disrupts the pain-signaling nerve endings that have been chattering away for months, which is why relief sometimes shows up before any real repair could have happened.

PRP works from the opposite direction. We draw your blood, spin it down, and concentrate your own platelets into a small volume that we inject precisely where the damage is. Platelets are packed with growth factors: PDGF, TGF-beta, VEGF, IGF-1, and a long list of others. What you're delivering is a concentrated biochemical payload, dropped directly into the injury.

Here's the way I explain it at the exam table. Shockwave prepares the ground. It improves circulation, calls repair cells to the neighborhood, and wakes up tissue that had gone quiet. PRP is the shipment of building material that arrives afterward. You can deliver excellent building material to a site with no road access and no crew, and not much happens. You can also build a beautiful road to an empty lot. The combination is what makes each part worth more.

That's a nice story, and nice stories are exactly what I distrust in this field. So let's go look at whether it holds up.

What the Combination Trials Actually Found

The most directly relevant recent work is a 2025 prospective randomized sham-controlled trial published in the Archives of Physical Medicine and Rehabilitation by Akçin and colleagues. They took 91 patients with lateral epicondylitis (tennis elbow) that had been going on for more than three months, and split them into three groups: PRP plus shockwave, sham PRP plus shockwave, and shockwave alone. Everybody did therapeutic exercise. Then they followed pain scores, grip strength, function questionnaires, ultrasound imaging of the common extensor tendon, and isokinetic testing at four and twelve weeks.

The group that got real PRP alongside shockwave came out ahead on pain during activity and at night at follow-up. By week twelve they outperformed the shockwave-only group across every parameter of the Patient-rated Tennis Elbow Evaluation, and beat both other groups on the Quick DASH disability score. Grip strength favored them too. That's a well-designed trial with a sham arm, which is not easy to do in this space, and you can read the full paper on PubMed.

Then there's a larger study on knees. A prospective clinical trial by Su and colleagues, published in 2019, randomized 180 patients with knee osteoarthritis into three arms: PRP injection alone, shockwave alone, or both together, five treatments over five weeks. All three groups improved on pain and function scores. What stood out was that the combination group scored better than either single-treatment group on visual analog scale pain, Lequesne Index, and WOMAC at every post-treatment time point. The authors concluded the two relieve pain synergistically. Worth noting honestly: knee range of motion didn't differ meaningfully between the three groups, so this was a pain and function effect, not a mechanical one. The study is indexed here.

Now for the part most clinics leave out. In 2018, Uğurlar and colleagues published a randomized controlled trial in the Journal of Foot and Ankle Surgery following 158 patients with chronic plantar fasciitis for a full 36 months, comparing shockwave, PRP, corticosteroid, and prolotherapy head to head. At three years, average pain scores in all four groups had drifted back toward baseline. Corticosteroid was the strongest performer in the first three months and shockwave was an effective option, but no single treatment held its ground across three years. You can read that one here.

I include that study every time I discuss this, because it's the guardrail. The combination data is encouraging over weeks and months. Nobody has shown that a combined protocol permanently immunizes a joint or a tendon over multiple years. Anyone who tells you otherwise is selling.

Sequencing Matters More Than People Think

If you accept the mechanism, the order and spacing of these treatments stops being a scheduling detail and becomes part of the therapy.

The way we generally run it at Magnolia is shockwave first, as a course rather than a single visit. Several sessions, roughly weekly, to get circulation and cellular recruitment moving in the target tissue. Then PRP lands into a treatment zone that's already biologically activated instead of into dormant, poorly perfused tissue. Some patients then get additional shockwave sessions afterward to keep the remodeling signal going while the growth factors do their work.

A few practical rules I don't bend on.

• We don't inject PRP the same day we do a heavy shockwave session on that exact tissue. Give it a short buffer.
• NSAIDs come off the table. Ibuprofen, naproxen, and their cousins blunt exactly the inflammatory cascade both treatments depend on. I ask patients to stop several days before and stay off for a couple of weeks afterward, using acetaminophen or ice if needed.
• Corticosteroid injections into the same site in the recent past change the plan. Steroid is catabolic to tendon tissue, and stacking regenerative work on top of a recently steroid-soaked tendon is working against yourself.
• Timeline expectations get set in writing. PRP is not a cortisone shot. Most people feel worse for a few days, then start noticing change somewhere around week four to six, with the real verdict at three months.

And loading is not optional. In a systematic review of systematic reviews on tendinopathy treatments published in the Scandinavian Journal of Medicine and Science in Sports by Irby and colleagues, eccentric exercise came out as the most consistently effective intervention across the entire body of randomized evidence, which you can verify here. Every combination protocol I run has a progressive loading program attached to it. The biology gives the tissue a chance to rebuild. Load is what tells it what to rebuild into.

Who This Is Actually For

I don't offer this to everyone with a sore shoulder, and the screening is most of the value.

The people who tend to be good candidates share a profile. The problem has lasted more than three to six months. They've already done a legitimate course of physical therapy, not two visits and a printout. There's identifiable degenerative tissue rather than a complete structural rupture. They're not diabetic with wildly uncontrolled glucose, not actively smoking (nicotine is brutal for tissue healing and it will undercut everything we do), and they're willing to commit to the rehab work between visits.

Conditions where I've found this pairing most worth considering include chronic lateral and medial epicondylitis, mid-portion Achilles tendinopathy, patellar tendinopathy, gluteal tendinopathy and greater trochanteric pain, rotator cuff tendinopathy without a full-thickness tear, and mild to moderate knee osteoarthritis in patients who aren't ready for or aren't candidates for replacement. If you want the specifics of how each piece works, our SoftWave shockwave therapy and PRP injection pages go deeper on each.

Who I turn away, or redirect. Complete tendon ruptures need a surgeon, not growth factors. Bone-on-bone end-stage arthritis with significant deformity is a joint replacement conversation, and pretending otherwise wastes a patient's money and time. Active infection, malignancy in the treatment field, pregnancy, and certain bleeding or anticoagulation situations are contraindications. Patients on chemotherapy or with platelet disorders won't produce useful PRP in the first place, since the whole treatment depends on your own platelets being healthy. And anyone whose real problem turns out to be a nerve entrapment or referred pain from somewhere else needs the right diagnosis, not a more expensive treatment for the wrong one.

That last category is more common than you'd guess. A meaningful share of "failed" regenerative treatment is actually correct treatment aimed at the wrong tissue.

The Honest Cost-Benefit Conversation

Combining two treatments means paying for two treatments, and neither is typically covered by insurance. That's a real consideration and I'd rather raise it than let a patient discover it later.

The way I frame it is this. If you have a straightforward problem you haven't seriously treated yet, start with the basics. Good physical therapy, load management, and time resolve a lot of tendon problems, and spending money on a combined protocol before you've done the fundamentals is putting a roof on a house with no foundation. Shockwave alone is a reasonable and less expensive first regenerative step for many people, and plenty of patients never need more than that.

The combination earns its keep in a narrower situation: significant chronicity, real functional limitation, a solid attempt at conservative care already behind you, and a clear surgical alternative you'd like to postpone or avoid. In that specific scenario, the incremental gains the trials showed start to look like they're worth something, because the alternative on the table is an operation with its own costs and its own recovery.

What I keep telling patients is that regenerative medicine works best when it's aimed carefully and paired with the unglamorous work, not when it's used as a shortcut around it. The tissue in a stubborn injury usually isn't beyond repair. It's stuck. Shockwave and PRP are two different ways of getting it unstuck, and used together in the right patient, they seem to do more than either does alone. If you've been carrying an injury around long enough that you've stopped expecting it to change, that's exactly the conversation worth having with us at Magnolia Functional Wellness in Southlake.

By Dr. Farhan Abdullah, DO | Medical Director, Magnolia Functional Wellness | Southlake, TX